TY  - JOUR
AU  - Shohdy, Kyrillus S.
AU  - Abdel-Rahman, Omar
PY  - 2018
TI  - Neurological complications of anti-PD-1 antibodies: shall we be more concerned?
JF  - Translational Cancer Research; Vol 7, Supplement 4 (April 26, 2018): Translational Cancer Research
Y2  - 2018
KW  - 
N2  - Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that target receptors expressed on surface of T-lymphocytes and tumor cells, those receptors such as programmed death receptor-1 (PD-1), and the programmed death-ligand 1 (PD-L1) mediate an immunosuppressive state characterized by T cell anergy that enables institution of tumorigenesis.
UR  - https://tcr.amegroups.org/article/view/19488